In a new research it is learned anti-inflammatory drugs could reduce heart attack and stroke risk. It is one of the biggest breakthrough in the treatment and the last such study was the advent of statins to lower cholesterol.

About 10,000 patients were studied and the team of researchers found there could be 15 percent reduction in the risk of a repeat heart attack.

However, the other questions are still unanswered like what will be the cost of treatment and what about its side-effects.

It is also found those who received the drug had high chances of fatal infections.

Meanwhile, the British Heart Foundation (BHF) said the new finding is still exciting and long-awaited trial and thous could help in saving lives.

As of now those who are suffering from heart attack are given cholesterol-lowering statins and blood-thinning drugs on routine basis to reduce the risk of repeat attacks, but in the new trial the patients were given anti-inflammatory drug at a gap of three months.

Details of the study were presented at the European Society of Cardiology meeting lately in Spanish city Barcelona.

Name of the drug is Canakinumab and it was initially developed by Novartis. The company also paid for the trial for the treatment of rheumatoid arthritis.

AdminHealthheart attack,stroke,study
In a new research it is learned anti-inflammatory drugs could reduce heart attack and stroke risk. It is one of the biggest breakthrough in the treatment and the last such study was the advent of statins to lower cholesterol. About 10,000 patients were studied and the team of researchers found...